ONCOSYNERGY INC has a total of 20 patent applications. Its first patent ever was published in 2006. It filed its patents most often in EPO (European Patent Office), United States and Australia. Its main competitors in its focus markets pharmaceuticals, measurement and biotechnology are CT HOSPITALIER UNIVERSITAIRE DE DIJON, ASCLEPIUMM LTD and MONOCLONAL ANTIBODIES THERAPEU.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 4 | |
#2 | United States | 4 | |
#3 | Australia | 3 | |
#4 | Brazil | 1 | |
#5 | Canada | 1 | |
#6 | China | 1 | |
#7 | Israel | 1 | |
#8 | Japan | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | WIPO (World Intellectual Property Organization) | 1 | |
#12 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement | |
#3 | Biotechnology | |
#4 | Organic fine chemistry |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Peptides | |
#4 | Analysing materials | |
#5 | Heterocyclic compounds | |
#6 | Special acyclic compounds |
# | Name | Total Patents |
---|---|---|
#1 | Carbonell W Shawn | 10 |
#2 | Yu Jin-Chen | 5 |
#3 | Chen Ruihong | 5 |
#4 | W Shawn Carbonell | 4 |
#5 | Barluenga Sofia | 3 |
#6 | Heck James | 3 |
#7 | Winssinger Nicolas | 3 |
#8 | Chabala John C | 3 |
#9 | Rubenstein Allan | 3 |
#10 | Shen Xiaodong | 2 |
Publication | Filing date | Title |
---|---|---|
EP3530284A1 | Anti-integrin beta1 antibody compositions and methods of use thereof | |
US2014135290A1 | Macrocyclic prodrug compounds useful as therapeutics | |
AU2009217315A1 | Macrocyclic prodrug compounds useful as therapeutics | |
EP1853223A2 | Local treatment of neurofibromas |